Evolution of Subclinical Hypothyroidism in Children Treated With Antiepileptic Drugs

Pediatric Neurology

Volumn 37, Issue 6, 2007, Pages 426-430

  Castro Gago, Manuel ^a   Novo Rodríguez, María Inés ^a   Gómez Lado, Carmen ^a   Rodríguez García, Javier ^b   Rodríguez Segade, Santiago ^b   Eirís Puñal, Jesús ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LIOTHYRONINE; PHENOBARBITAL; THYROTROPIN; THYROXINE; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; HYPOTHYROIDISM; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; MALE; THYROID HORMONES;

EID: 36049043714     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.07.003     Document Type: Article

References (47)

1. Tunbridge W.M., Evered D.C., Hall R., et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol 7 (1977) 481-493 (Oxf)
2. Staub J.J., Althaus B.U., Engler H., et al. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92 (1992) 631-642
3. Evered D.C., Ormston B.J., Smith P.A., Hall R., and Bird T. Grades of hypothyroidism. Br Med J 1 (1973) 657-662
4. Toft A.D. Thyroxine therapy. N Engl J Med 331 (1994) 174-180
5. Bastenie P.A., Vanhaelst L., Bonnyns L., Neve P., and Staquet M. Preclinical hypothyroidism: A risk factor for coronary disease. Lancet 1 (1971) 203-204
6. Bastenie P.A., Vanhaelst L., and Neve P. Coronary artery disease in hypothyroidism: Observations in preclinical myxoedema. Lancet 2 (1967) 1221-1222
7. Bastenie P.A., Vanhaelst L., Goldstein J., and Smets P. Asymptomatic autoimmune thyroiditis and coronary heart disease: Cross sectional and prospective studies. Lancet 2 (1977) 155-158
8. Anonymous. Subclinical hypothyroidism. [Editorial]. Lancet 1 (1986) 251-252
9. Bigos S.T., Ridway E.C., Kourides T.A., and Maloof F. Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 46 (1978) 317-325
10. Tumbridge W.M.G., Evered D.C., and Hall R. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol 7 (1977) 495-508 (Oxf)
11. Oppenheimer J.H., Fisher L.V., Nelson K.M., and Jailer J.W. Depression of the serum protein-bound iodine level by diphenylhydantoin. J Clin Endocrinol Metab 2 (1961) 252-262
12. Fischsel H., and Knöpfle G. Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Epilepsia 19 (1978) 323-336
13. Rousso I., Pharmakiotis A., Gatzola M., Karatza E., Tourkantonin A., and Sklavounou-Tsouroutsoglou S. Effects of phenobarbital, diphenylhydantoin and carbamazepine on thyroid function in epileptic children. Acta Endocrinol 265 (1984) 48-49 (Copenh)
14. Liewendahl K., Majuri H., and Helenius T. Thyroid function tests in patients on long term treatment with various anticonvulsants drugs. Clin Endocrinol 8 (1978) 185-191
15. Rootwelt T., Ganes T., and Johannessen S.I. Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 38 (1978) 731-736
16. Connacher A.A., Borsey D.Q., Browning M.C.K., Davidson D.L.W., and Jung R.T. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. Postgrad Med J 63 (1987) 841-845
17. Gómez J.M., Cardesin R., Virgili N., Moreno I., Navarro M.A., and Montaña E. Estudio de los parámetros de función tiroidea y de la TSH en pacientes tratados con fármacos anticonvulsivantes. An Med Interna 6 (1989) 235-238
18. Isojärvi J.I.T., Pakarinen A.J., Ylipalosaari P.J., and Myllylä V.V. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Neurol 47 (1990) 670-676
19. Isojärvi J.I.T., Pakarinen A.J., and Myllylä V.V. Thyroid function with antiepileptic drugs. Epilepsia 33 (1992) 142-148
20. Zhu S.Q., Liu X.M., Ruan X.Z., and Cai Z. Changes of thyroid hormone levels in epileptic patients. J Tongji Med Univ 14 (1994) 119-123
21. Tiihonen M., Liewendahl K., Waltimo O., Ojala M., and Valimaki M. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: A placebo-controlled thyroxine therapy trial. Epilepsia 36 (1995) 1118-1125
22. Strandjord R.E., Aanderud S., Myking L.O., and Johannessen S.I. Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy. Acta Neurol Scand 63 (1981) 111-121
23. Connell J.M.C., Rapeport W.G., Gordon S., and Brodie M.J. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. Eur J Clin Pharmacol 26 (1984) 453-456
24. Tanaka K., Kodama S., Yokohama S., et al. Thyroid function in children with long-term anticonvulsant treatment. Pediatr Neurosci 13 (1987) 90-94
25. István I., Agota P., Bálintné S., and Ilona G. Tartós anticonvulsiv kezelésben részesült gyermekek pajzsmirigy-müködése. Orv Hetil 20 (1988) 1202-1203
26. Isojärvi J.I.T., Pakarinen A.J., and Myllylä V.V. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 46 (1989) 1175-1178
27. Isojärvi J.I.T., Airaksinen K.E.J., Repo M., Pakarinen A.J., Salmeia P., and Myllylä V.V. Carbamazepine, serum thyroid hormones and myocardial function in epileptic patients. J Neurol Neurosurg Psychiatry 56 (1993) 710-712
28. Isojärvi J.I.T., Airaksinen K.E.J., Mustonen J.N., et al. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia 36 (1995) 810-816
29. Yüksel A., Katal A., Cenani A., and Yalçin E. Serum thyroid hormones and pituitary response to thyrotropin-releasing hormone in epileptic children receiving anti-epileptic medication. Acta Pediatr Jpn 35 (1993) 108-112
30. Lüdorf K., Christiansen P., Hansen J.M., and Lund M. The influence of phenytoin and carbamazepine on endocrine function: Preliminary results. In: Penry K.I. (Ed). Epilepsy. The Eighth International Symposium (1977), Raven Press, New York 209-213
31. Yeo P.P., Bates D., Howe J.G., et al. Anticonvulsants and thyroid function. Br Med J 1 (1978) 1581-1583
32. Bentsen K.D., Gram L., and Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neurol Scand 67 (1983) 235-241
33. Ericsson U.-B., Bjerre I., Forsgren M., and Ivarsson S.A. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine and valproic acid. Epilepsia 26 (1985) 594-596
34. Surks M.I., and DeFesi C.R. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine: A paradox resolved. JAMA 275 (1996) 1495-1498
35. Faigle J.W., and Feldmann K.F. Carbamazepine: chemistry and biotransformation. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed. (1995), Raven Press, New York 499-513
36. Eirís-Puñal J., Del Río-Garma M., Del Río-Garma M.C., Lojo-Rocamonde S., Novo-Rodríguez I., and Castro-Gago M. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 40 (1999) 1761-1766
37. Isojärvi J.I.T., Turkka J., Pakarinen A.J., Kotila M., Rättyä J., and Myllylä V.V. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 42 (2001) 930-934
38. Vainionpää L.K., Mikkonen K., Rättyä J., et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 45 (2004) 197-203
39. Hamed S.A., Hamed E.A., Kandil M.R., El-Shereef H.K., Abdellah M.M., and Omar H. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 66 (2005) 173-183
40. Cansu A., Serdaroglu A., Çamurdan O., Hirfanoglu T., Bideci A., and Gücüyener K. The evaluation of thyroid function, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oscarbazepine and valproate. Epilepsia 47 (2006) 1855-1859
41. Prichard J.W., and Ranson B.R. Phenobarbital: Mechanisms of action. In: Levy R.H., Mattson T.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed. (1995), Raven Press, New York 359-369
42. Dodson W.E., and Rust R.S. Phenobarbital: Absorption, distribution, and excretion. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed. (1995), Raven Press, New York 379-387
43. Fariello R.G., Varasi M., and Smith M.C. Valproic acid: Mechanism of action. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed. (1995), Raven Press, New York 581-588
44. Aanderud S., and Strandjord R.E. Hypothyroidism induced by antiepileptic therapy. Acta Neurol Scand 61 (1980) 330-332
45. Hegedüs L., Hansen J.M., Lüdorf K., Perrild H., Feldt-Rasmussen U., and Kampmann J.P. Increased frequency of goitre in epileptic patient on long-term phenytoin or carbamazepine treatment. Clin Endocrinol 23 (1985) 423-429
46. Löscher W., and Schmidt D. Increase of human plasma GABA by sodium valproate. Epilepsia 21 (1980) 611-615
47. Perelman R. Pédiatrie practique III: Maladies des glands endocrines. 2nd ed. (1994), Maloine, Paris 6-23